Table 3.

Phase II: patient’s characteristics.

Patient’s Characteristics	Arm A (Nab-FOLFIRI)		Arm B (Nab-FOLFOX)
	N	%	N	%
Sex
Male	26	62	27	64
Female	16	38	15	36
Age
Median	60 (range 29–75)		64 (range 47–74)
ECOG
PS 0	25	60	29	69
PS 1	17	40	13	31
Site of primary
Head	18	43	19	45
Body/tail	24	57	23	55
Previous surgery
Yes	12	29	4	10
Previous adjuvant treatment
Yes	8	19	1	2
Biliary stenting	7	17	6	14
M + liver	33	79	30	71
Ca 19.9 (U/mL)
median	566 (range 3–634,657)		1101 (range 0–167,350)